research articl congenit blood transfus transmiss chaga disease: framework mathemat model edneid ramalho ,1 jone albuquerque,1,2 cludio cristino,1 virginia lorena,3 jordi gmez prat,4 clara prat ,5 daniel lpez 5 1universidad feder rural pernambuco, departamento estatstica e informatica, recife, pe, brazil 2lika laboratorio imunopatologia keizo assami, ufpe, recife, pe, brazil 3fiocruz fundacao oswaldo cruz - pernambuco, recife, brazil 4unitat salut internacional, prosics, programa especi malalti infeccios vall dhebron-drassanes, barcelona, spain 5universitat politecnica catalunya barcelonatech, departa fsica, escola superior dagricultura barcelona, castelldefels, spain correspond address clara prats; receiv 21 2018; accept 4 octob 2018; publish 1 novemb 2018 guest editor: miguel fuent copyright 2018 edneid ramalho et al. open access articl distribut creativ common attribut license, permit unrestrict use, distribution, reproduct medium, provid origin work properli cited. chaga diseas american trypanosomiasi import health problem latin america. mobil latin american popul world, countri vector presenc start report diseas cases. develop determinist compartment model order gain insight diseas dynam scenario vector presence, consid congenit transmiss transmiss blood transfusion. model evalu epidemiolog effect control measures. appli demograph data spain sensit analysi perform model paramet associ control strategies. 1. introduct chaga diseas american trypanosomiasi caus protozoan parasit trypanosoma cruzi, import health problem latin america. effect trans- mission rout contact triatomin bug (the diseas vector) feces. transmiss rout occur blood transfusion, organ transplantation, congenit transmiss [1]. case oral transmiss report brazil, venezuela, colombia, mexico, argentina, bolivia [2]. diseas present initi acut phase, gener asymptomatic, subsequ chronic phase, present clinic manifest (cardiac, digestive, and/or neurological) [1]. 1960 drug chaga diseas treatment benznidazol nifurtimox, great effici treatment start earli control diseas progress chronic case [1, 3]. latin american countries, argentina, bolivia, brazil, chile, paraguay, uruguay, peru, receiv pan american health organ (paho) intern certif diseas elimina- tion main vector triatoma infestans, diseas challeng [4]. accord theworld health organization, 8 million peopl infect worldwid 10,000 peopl die year diseas clinic manifest [1]. moreover, estim 25 million peopl risk acquir disease. 30-40% infect peopl develop cardiomyopathy, digest megasyndromes, [5]. 2000, case diseas start report nonendem countri european countries, canada, usa, japan, australia, larg flow latin american immigr [6]. 2010, world health assem- bly approv resolution, wha 63.20 [7], recogn increas number case establish wai track hindawi complex volum 2018, articl id 1589016, 10 page 2 complex transmiss routes.th global cost diseas similar rotaviru cervic cancer [8]. 2009, 4,290 case diagnos europe, compar estim incid rang 68,000 122,000 cases, 95% case nondiagnosed, reflect difficulti track infect peopl [9, 10]. uncertainti real number case country, estim base paho [11] schmuni et al. 2014 [12]. spain european countri latin american immigrants, rank second world list, unit state america [13]. 2008, approxim 4 million immigr spain. 1.5 million themwer born countri endem chaga diseas and, therefore, potenti carrier diseas [14]. case diseas blood transfus spain detect 1984, case 1995 2004 [15]. case congenit transmiss report [16, 17]. silent evolut infect result underdiagnoses, complet reliabl data disease. therefore, mathemat model partic- ularli us tool studi diseas spread control. mathemat model studi order assess differ aspect chaga diseas control strategies. instance, velasco-hernandez et al. [18] consid compartment model humans, vectors, transmiss blood transfusion. inaba sekin [19] consid humans, vectors, blood transfus infect ag depend infectivity. congenit transmiss consid massad [4], raimundo et al. [20], coffield et al. [21]. fabrizio et al. [22] explor interhuman model, consid congenit transmiss blood transfus transmission. work, present novel determinist compart- mental model consid congenit blood transfus main mode transmiss demograph data spain. aim gain insight dynam diseas scenario vector evalu epidemiolog impact implement control strategi like improv surveil blood transfus treatment infect newborns. introduc cure rate infect individu verifi affect diseas dynamics.thi cure ratemean decreas number parasit insid host, consequ decreas risk develop clinic manifestation. 2. materi method 2.1. model description. introduc determinist com- partmentalmodel forchaga transmissionwithout vector presence. model distinguish latin american peopl countri activ vector transmiss nativ immigr countri vector transmission. split men women differ compart order vertic transmiss account. therefore, popul classifi compartments: (1) v: healthi men countri activ vector transmission; (2)v: infect men countri activ vector transmission; (3) : healthi men countri vector trans- mission; (4) : infect men countri vector trans- mission; (5) wv: healthi women countri activ vector transmission; (6) v: infect women countri activ vector transmission; (7) : healthi women countri vector transmission; (8) : infect women countri vector transmission. model simul analyz number individu time compartments. pro- cess consid drive dynam simplest possible, keep mind essenc system structure, object model question answered. reason look simplic various. theoret perspective, strictli gradual increas complex essenti model develop order elucid differ driver overal dynamics. social perspective, simplic facilit necessari interact nonmodel like commun health workers, social scientists, patient associ order seek real feasibl applications. process consid current model birth, mortality, flow compartments. infect flow associ possibl causes: blood transfus congenit transmission. figur 1 show flowchart model.th assumpt dynam transmiss following: (i) assum vertic transmiss propor- tional number infect women. peopl born spain consid vector compartment, is, , famili origin latin american. (ii) consid birth rate women countri vector presence. assum 50% descen- dant women 50% men, simplicity. (iii) woman infected, probabl infect son daughter. (iv) paramet stand mortal rate healthi people. infect individu assum mor- taliti rate induc diseas , > . (v) flow health infect class blood transfus consid result interact suscept infect people. con- sider differ blood organ donat rate popul countri vector countri vector. paramet stand yearli blood donat rate. complex 3 1 2 3 4 5 6 7 8 figur 1: flow chart dynam propos model. letter insid box indic number individu compartment: infect women countri vector (v), healthi women countri activ vector transmiss (v), infect men countrywith activ vector transmiss (v), healthymen fromcountrywith activ vector transmiss (v), infectedwomen fromcountri vector transmiss ( ), healthi women countri vector transmiss ( ), infectedmen countri vector transmission( ), healthi men countri vector transmiss ( ). death rate healthi peopl death rate infect people. rate infect blood transfusion. dash line indic births. newborn fromv infect femal (1), healthi femal (2), healthi male (3), infect male (4). occur newborn infect femal (5), healthi femal (6), infect male (7), healthi male (8). healthi womenv gave birth healthi newborn (flow shown). (vi) consid proport donat blood potenti contamin t. cruzi. donat made, health servic carri control screening. consid probabl effect surveil screen donat blood samples, 1 probabl infect sampl detected, reach receptor, infect her. way, rate healthi person infect parasit infect person proport product = (1 ). consid transfus rate individuals. (vii) suppos infect individu cure rate treatment. cure rate mean reduct number parasit insid host, reduc chanc clinic manifestation. consid yearli percentag infect individu diagnos receiv treatment. consid treatment effectiveness, write = . detect patient receiv treatment differ reason (e.g., report difficulti access [29]) distinguish nondiagnos individu model. (viii) nomigr flow (neither immigr emigra- tion) consid themodel, relev current purpose. accord assumpt above, model rep- resent follow ordinari differenti equat (1)-(8): = 0.5 ( +v) + 0.5 (1 + ) ( +v) + (1 ) ( ) (1) = 0.5 ( +v) + 0.5 (1 + ) ( +v) + (1 ) ( ) (2) v = v v (1 )v ( ) (3) v = v v (1 )v ( ) (4) = 0.5 ( +v) (1 ) ( + ) + (1 ) ( ) (5) = 0.5 ( +v) (1 ) ( + ) + (1 ) ( ) (6) v = (1 )v ( ) ( + )v (7) 4 complex v = (1 )v ( ) ( + )v (8) = + +v+v number infect individu total population. formul evalu model behavior help inform known unknown, analyz rel import parameters, understand system dynamics, observ long-term dynam base control action carri out. 3. result 3.1. paramet estimation. order evalu trend import factor dynam system, necessari attribut paramet valu model. thus, modelwa fed avail data spain.th divers model paramet fix requir us differ data sources. explor data availability, chose 2007 start point simul guarante access necessari information. sourc obtain valu describ below. 3.1.1. birth rate vertic transmission. 2007 birth rate spain 10.9 1,000 inhabit [23]. studi perform matern clinic barcelona, munoz et al. [24] report preval 3.4% pregnant latin american 7.3% newborn infected. then, set birth rate = 0.0109 year1 probabl vertic transmiss = 0.073. 3.1.2. mortal rates. 2007 mortal rate spain 8.5 1,000 inhabit [25]. cunuba et al. [26] publish systemat review mortal attribut chaga disease.th author annuallymort rate chaga patient twice higher non-chaga patient moder clinic group (0.16 (chagas) vs. 0.08 (non- chagas) rr = 2.10, 95% ci: 1.52-2.91).therefore, set = 0.0085 year = 2 = 0.017. 3.1.3. transmiss blood transfusion. defin rate transmiss blood transfus = , donat rate year proport potenti infect blood samples. proport potenti infect blood sampl report 0.67 1,000 [27]. rate blood donat spain 2007 33.4 1,000 inhabit [28]. then, rate infect blood transfus calcul 0.00022378 year. 3.1.4. control strategies. action control increas new case chaga diseas incorpor model ((1)-(8)) assum control parameters. consid kind control strategies: (i) increas proport infect newborn treated, mean increas paramet model simulation. (ii) increas surveil blood transfusion, mean increas paramet model simulation. moreover, assum cure rate diagnos treat infect individuals. model simulation, increas paramet . summari paramet simul list tabl 1. 3.2. numer simulations. popul spain 2007 45,226,803 [30] 1,638,694 immigr countri vector presenc potenti chaga dis- eas carriers. estim number infect individu 53,134. besides, take account demograph characterist population, estim number infect women childbear ag spain 24,000 [24, 27]. base that, initi condit set (0) = 21, 791, 055, (0) = 0,v(0) = 792, 780,v(0) = 29, 134, (0) = 21, 792, 055, (0) = 0,v(0) = 792, 780,v(0) = 24, 000. us model (1)-(8), simul cumul number infect peopl time. numer simul perform softwar r 3.5.0, integr ((1)-(8)) rungekutta fourth-ord method, paramet shown tabl 1 initi condit set above. time step year time rang simul 40 years. 3.3. total infect population. dynam total number infect individu ( = + + v + v) simul 40 year order observ epidemiolog behavior given model. observ decreas behavior total number infect peopl time shown figur 2. result higher death rate attribut infect peopl fact migrat flow considered, result decreas rate chang total number infected. end 40 year simulation, 48% reduct number total infect compar initi value. 3.4. compar effect transmiss routes. number infect peopl immigr countri vector presence, quantiti number new case disease, i. e., cumul number new infect aris blood transfus congenit transmission, repres sum individu- al compart . compar differ diseas dynam rout infect considered, displai figur 3.the result congenit transmiss higher impact transmiss blood transfusion, caus 38% new infections. 3.5. control strategies. control strategi consid- ered, mentioned, treatment infect newborn complex 5 tabl 1: paramet numer simul propos model (1)-(8). paramet mean valu sourc birth rate (year1) 0.0109 [23] probabl vertic transmiss 0.073 [24] mortal rate (year1) 0.0085 [25] mortal rate diseas (year1) 0.0017 [26] rate infect infect blood (year1) 0.00022378 [27, 28] cure rate (year1) proport new born treat probabl effici surveil 2017 2027 2037 20472007 time (years) 0 10 20 30 40 50 ta l nf ec te d (i n 1, 00 0 pe op le ) figur 2: dynam number total infect peopl 40 year simul consid death rate diseas twice natur death rate migrat flows. 2017 2027 2037 20472007 time (years) 0 100 200 300 400 n ew fe ct ed congenit transmiss transmiss blood transfus figur 3: comparison number cumul new infect time singl transmiss rout considered. = 60% = 80% = 100% = 20% = 40% control 0 100 200 300 400 500 600 c um ul iv e n ew fe ct ed 2017 2027 2037 20472007 time (years) figur 4: sensit analysi cumul number newli infect individu vari , i.e., proport treatment infect newborn. () surveil blood transfus ().these strategi simulated, isolated, combined. 3.5.1. consid treatment infect newborns. simulation, evalu effect perform control strategi newborns. paramet associ- at control strategi , repres proport successfulli treat infect newborns. paramet vari 20%. paramet model remain constant tabl 1, paramet repres control blood transmiss set zero. figur 4 displai result sensit analysi cumul number newli infect individuals. compar tendenc scenario control (figur 2), obtain percentag reduc- tion cumul number new infect 40 year shown tabl 2. treat 100% infect newborn mean cumul number newli infect individ- ual aris transmiss blood transfusion. 6 complex 2017 2027 2037 20472007 time (years) 0 100 200 300 400 500 600 c um ul iv e n ew fe ct ed = 60% = 80% = 100% = 20% = 40% control figur 5: sensit analysi cumul number newli infect individu vari , i.e., probabl effect surveil blood transfusions. tabl 2: percentag reduct variat paramet proport treatment infect newborn. valu reduct (%) 20% 12.5 40% 24.9 60% 37.29 80% 49.64 100% 61.95 tabl 3: percentag reduct number new case variat paramet probabl effect surveil blood transfusion. valu reduct (%) 20% 7.75 40% 15.49 60% 23.22 80% 30.93 100% 38.63 3.5.2. control blood transfusion. simulation, evalu effect perform control strategi onblood transfusion. figur 5 displai result sensit analysi cumul number newli infect indi- vidual vari probabl effect surveil blood transfusions, paramet remain constant paramet associ control infect newborn set zero. obtain percentag reduct cumul number newli infect 40 year simulation, compar control scenario (figur 2), shown tabl 3. probabl effect tabl 4: percentag reduct number new case variat paramet associ control strategi (percent infect newborn treated) (probabl effect surveil blood transfusion). paramet valu reduct (%) = 20%, = 20% 20.2 = 40%, = 20% 32.6 = 60%, = 40% 52.6 = 80%, = 60% 72.6 = 100%, = 80% 92.4. = 60%, = 40% = 80%, = 60% = 100%, = 80% = 20%, = 20% = 40%, = 20% control 0 100 200 300 400 500 600 c um ul iv e n ew fe ct ed 2017 2027 2037 20472007 time (years) figur 6: sensit analysi cumul number newli infect appli combin control: increas proport treatment infect newborn (paramet ) surveil- lanc blood transfus transmiss (paramet ). surveil reach 100%, new case congen- ital transmission. 3.5.3. combin control. sensit analysi perform vari paramet associ control strategi time. figur 6 show result combin control, vari simultaneously. result percentag reduct cumul number newli infect compar control scenario end 40 year simul shown tabl 4. explor effect certain cure rate dynam infect individuals. effect treatment nifurtimox and/or benznidazol patient chronic indetermin phase chaga diseas 7- 8% [3]. accord [10], index underdiagnosi spain rang 92.0-95.6%. justifi low valu consid percent detect individu model simulation, complex 7 d = 20%,= 30%,= 30% d = 25%,= 40%,= 40%d = 5%,= 10%,= 10% d = 15%,= 20%,= 20% control 2017 2027 2037 20472007 time (years) 0 100 200 300 400 500 600 c um ul iv e n ew fe ct ed figur 7: sensit analysi consid detect treatment infect individu , treatment infect newborn , surveil blood transfus transmiss . 2017 2027 2037 20472007 time (year) 0 50 100 150 200 250 300 c um ul iv e n ew fe ct ed figur 8:the result simul interrupt control. paramet associ control strategi = 25% (detect infect people), = 80% (treatment infect newborn), = 80% (effect surveil blood transfusion). control strategi appli 10 year simulation. 15 year application, control strategi stopped. includ paramet . base that, set treatment effect = 7.5% vari detect treatment infect individu . cure rate assess = 7.5% . detect treatment infect patient difficult, mainli asymptomat characterist diseas [10] barrier health care access limit ownmispercept tabl 5: percentag reduct total number infect individu vari proport detect treatment infect individu . valu reduct (%) = 5% 13.93 = 15% 36.23 = 20% 45.11 = 25% 52.76 tabl 6: percentag reduct paramet variation. paramet reduct (%) d = 5%, = 10%, = 10% 22.63 d = 15%, = 20%, = 20% 48.78 d = 20%, = 30%, = 30% 60.51 d = 25%, = 40%, = 40% 69.75 diseas [29]. therefore, vari paramet 0 25%. percentag reduct total number infect individu initi year simul 40 year shown tabl 5. cumul number new infect strongli affect introduct cure rate. figur 7 displai sensit analysi vari paramet , , . correspond percentag reduct compar scenario control end 40 year simul paramet combin displai tabl 6. 3.5.4. interrupt control. interest scenario explor model simul interrupt control. simul cumul number new case appli control strategi year control, follow control period 15 years, interrupt period. detect proport 25%, treatment success 80% infect newborns, surveil blood transfus 80% effective. figur 8 displai result. years, number new case increas infect peopl population. control strategi performed, number new case decreas infect peopl treat avoid transmiss congenit blood transfus routes. control strategi stopped, number new case start increas again, infect newborn peopl infect blood transfus time. 4. discuss work, compartment mathemat model evalu dynam chaga diseas scenario vector absence, transmiss occur congenit blood transfus routes. 8 complex result that, total number infect individu present decreas behavior (fig- ur 2), 40 year reduct reach half initi value, assum death rate infect individ- ual twice rate healthi peopl immigration. mean diseas taken seriously, present popul long period time [31], vector absence, gener burden public health prepar provid patient care conduct adequ treatment order prevent long-term diseas manifestations. accord model, transmiss exclus blood transfus smaller impact number new case compar transmiss exclus congenit rout (figur 3). low preval blood bank countri vector absence, oftentim self-exclus latin american immigr transfus services, explain fact [9]. nevertheless, blood screen sustain vital prevent infect transfus organ transplant nonendem countries. optim blood transfus safeti screen resolut world health assembl control elimin chaga diseas (wha 63.20) [7]. spain, control strategi base select donor screen questionnair implement 2005. donat at-risk individu accept blood test [15]. prevent transfus contamin blood sampl identifi infect people. simul result plot figur 4 5 displai applic isol control strategies. that, infect newborn treat total effect surveil blood bank reached, reduct number new case compar scenario control 100% achieved. themodel simul show applic com- bine control strategi (i.e., treatment infect newborn effect surveil blood transfusion) lead signific reduct number new case compar scenario control (figur 6). instance, treat 80% infect newborn have 60% effect surveil blood bank entail 72.6% new infect compar scenario control. import highlight that, standard protocol deal diseas control, qualiti servic import difficult measured. sense, studi patient percept experi includ protocol order increas qualiti assess services. fact justifi valu paramet associ control strategies, vari 20% 100% effectiveness. congenit transmission, import fact mention major latin american immigr italy, japan, switzerland, australia, new zealand women childbear age, highlight import program screen pregnant women. program lead earli detect congenit transmission, state world health assembl [7]. 2014 tuscani region itali legisl screen pregnant women area consid endem [8]. spain, catalonia, valencia, galicia region protocol screen pregnant women latin america 2014 [8]. countri nation program diseas prevent [32, 33]. adopt screen protocol extrem import identif treatment infect newborn good therapeut result [24]. detect infect peopl difficult asymptomat characterist diseas lead underestim number current case [10], model test effect cure rate treatment. cure rate understood reduct number parasit insid host body. treatment chronic case reduc long-term complic caus diseas [3, 34]. nevertheless, treatment access guarante diagnos patient elimin exist barrier [29]. women childbear age, detect treatment prevent congenit transmiss [35, 36]. model result accord fact detect treatment infect peopl impact cumul number new infect (figur 7). import strategi track infect peopl activ surveil primari care commun action order identifi pregnant women follow children [37]. great effort conduct kind strategy, cases, infect peopl lost. simul result reduct number total infect peopl 52.76% 25% infect peopl detect treat compar scenario control. detect treatment reduc number new case combin treatment infect newborn surveil blood transfusions. example, detect 25% infect individuals, treat 40% infect newborns, have surveil blood bank 40% efficient, number new case 70% smaller compar scenario control. import control strategi sustained; otherwise, diseas elimin longer achieved. figur 8 displai result simul control appli limit period interrupted. period control applic performed, number new case decreases, start increas control stops. model appli spain, countri vector presence, similarli appli countrieswith vector absenc order carri diagnosi current epidemiolog situat determin order magnitud control strategi effects. recal model simplifi descrip- tion reality. consequently, entail necessari simplifica- tion order focu state aims. propos model suffici import sustain control strategi consid order advanc steadili diseas elimination. otherwise, present popul long time caus long-term clinic manifest burden public health system. aspect explor futur work as, example, introduct migrat rates. nevertheless, migrat flow straightforward effect complex 9 chaga diseas dynam nonendem countries, usual unpredict difficult control. therefore, silico experi explor differ scenario propos possibl action revert neg epidemiolog effects. control strategi incorpor model test screen specif collect order detect (and treat, necessary) new asymptomat case at-risk popul [38]. case women childbear age, treat infect women futur pregnanc prevent congenit transmiss [36]. finally, import point inter- transdisciplinari work amongmodelers, health practitioners, commun health workers, patient associations, context-specif actor essenti gener imple- ment effect tool decis make public health control policies. sense, develop simpl model user-friendli simul platform guarante necessari collabor model expert nonexpert feasible. 5. conclus mathematicalmodel valuabl tool explor differ scenario relat diseas spread, estim epidemiolog impact control strategi implemented. interdisciplinari collabor extrem import context improv decis make implement public polici order reduc diseas burden public health. data avail epidemiolog demograph data support studi previous report studi datasets, cited. process data avail correspond author request. conflict author declar conflict public paper. acknowledg research partial fund coordenacao aperfeicoamento pessoal nvel superior, brasil (capes), financ code 001. best thank dr. pedro albajar-vina import comment suggestions. preliminari result articl present xiv workshop chaga diseas (xiv taller sobr la enfermedad chagas) intern confer digit health. refer [1] who, world health organization. chaga diseas (ameri- trypanosomiasis), 2017, factsheets/fs340/en/. [2] import multidisciplinari approach deal new epidemiolog scenario chaga diseas (global health), acta tropica, vol. 151, pp. 1620, 2015. [3] p. a. s. junior, i.molina, s.m. f.murta et al., experiment clinic treatment chagasdisease: review,theamerican journal tropicalmedicin andhygiene, vol. 97, no. 5, pp. 1289 1303, 2017. [4] e. massad, elimin chaga diseas brazil, epidemiolog infection, vol. 136, pp. 11531164, 2008. [5] a. rassi jr., a. rassi, j. a. marin-neto, chaga disease, lancet, vol. 375, no. 9723, pp. 13881402, 2010. [6] c. di girolamo, c. bodini, b. marta, a. ciannameo, f. cacciatore, chaga diseas crossroad intern migrat public health policies: nation screen enough, eurosurveillance, vol. 15, no. 37, 2011, eurosurveillance. [7] world health organ (who), chaga disease: control elimination. resolut decis wha 63.20, who, geneva, 2010, diseases/mediacentre/wha 63.20 eng.pdf. [8] a. requena-mendez, p. albajar-vinas, a. angheben et al., health polici control chaga diseas transmiss european countries, plo neglect tropic diseases, vol. 8, no. 10, p. e3245, 2014. [9] a. requena-mendez, e. aldasoro, e. lazzari et al., preva- lenc chaga diseas latin-american migrant live europe: systemat review meta-analysis, plo neglect tropic diseases, vol. 9, no. 2, p. e0003540, 2015. [10] l. basile, j. jansa, y. carlier et al., chaga diseas european countries: challeng surveil system, chaga diseas europe, vol. 16, no. 37, 2011. [11] organizacion panamericana la salud, estimacion cuantita- tiva la enfermedad chaga en la americas. spanish, 2006, [12] g. a. schmuni z. e. yadon, chaga disease: latin american health problem world health problem, acta tropica, vol. 115, no. 1-2, pp. 1421, 2010. [13] m. navarro, b. navaza, a. guionnet, r. lopez-velez, chaga diseas spain: need public health measures,plo neglect tropic diseases, vol. 6, no. 12, 2012. [14] m. piron, m. verges, j. munoz et al., seropreval try- panosoma cruzi infect at-risk blood donor catalonia (spain), transfusion, vol. 48, no. 9, pp. 18621868, 2008. [15] a. angheben, l. boix, d. buonfrat et al., chaga diseas transfus medicine: perspect non-endem countries, blood transfusion, vol. 13, no. 4, pp. 540550, 2015. [16] c. riera, r. fisa, c. martin, a. guarro, m. castro, j. m. jorba et al., congenit transmiss trypanosoma cruzi europ (spain): case report,theamerican journal tropic medicin hygiene, vol. 75, no. 6, pp. 10781081, 2006. [17] j. munoz, m. portus, m. corachan, v. fumado, j. gascon, congenit trypanosoma cruzi infect non-endem area, transact royal societi tropic medicin hygiene, vol. 101, no. 11, pp. 1161-1162, 2007. [18] j. x. velasco-hernandez, amodel chaga diseas involv transmiss vector blood transfusion, theoret popul biology, vol. 46, pp. 131, 1994. [19] h. inaba h. sekine, mathemat model chaga diseasewith infection-age-depend infectivity,mathemat biosciences, vol. 190, no. 1, pp. 3969, 2004. 10 complex [20] s. m. raimundo, e. massad, h. m. yang, model congenit transmiss chaga disease, biosystems, vol. 99, pp. 215222, 2010. [21] d. j. coffield jr., a. m. spagnuolo, m. shillor et al., amodel chaga diseas oral congenit transmission, plo one, vol. 8, no. 6, 2013. [22] m. fabrizio, n. j. schweigmann, andn. j. bartoloni, model inter-human transmiss dynam chaga disease: analysi application, parasitology, vol. 141, pp. 837848, 2014. [23] theworld bank, birth rate, crude (per 1,000 people), data.worldbank.org/indicator/sp.dyn.cbrt.in?locations=es. [24] j. munoz, o. coll, t. juncosa et al., preval vertic transmiss trypanosoma cruzi infect preg- nant latin american women attend 2 matern clinic barcelona, spain,clin infecti diseases, vol. 48, no. 12, pp. 17361740, 2009. [25] theworld bank, death rate, crude (per 1,000 people), data.worldbank.org/indicator/sp.dyn.cdrt.in?locations= esview=chart. [26] z.m. cucunuba,o. okuwoga,m.-g. basanez, p. nouvellet, increas mortal attribut chaga disease: systemat review andmeta-analysis, parasit & vectors, vol. 9, p. 42, 2016. [27] r. a. gallastegui, c. c. izaguirre, e. c. brustenga et al., enfermedad chaga y donacion sangre, ministerio sanidad y poltica social, 2009, ministerio sanidad y poltica social. [28] j. a. garca-erce, a. campos, m. munoz, blood donat blood transfus spain (1997-2007): effect demograph chang univers leucoreduction, blood transfusion, vol. 8, p. 100, 2010. [29] m. navarro j. j. lo santos, access chaga diseas treatment non-endem countries: case spain, lancet global health, vol. 5, p. e577, 2017. [30] world bank, population, total, .org/indicator/sp.pop.totl?locations=es. [31] j. coura p. vinas, chaga disease: new worldwid challenge, nature, pp. 56-57, 2010. [32] y. jackson f. chappuis, chaga diseas switzerland: histori challenges, eurosurveillance, vol. 16, 2011. [33] k. imai, t. maeda, y. sayama et al., chronic chaga diseas advanc cardiac complic japan: case report literatur review, parasitolog international, vol. 64, no. 5, pp. 240242, 2015. [34] d. l. fabbro, m. l. streiger, e. d. arias, m. l. bizai, m. del barco, n. a. amicone, trypanocid treatment adult chronic chaga diseas live santa fe citi (argentina), mean follow-up 21 years: parasitological, serolog clinic evolution, journal brazilian societi tropic medicine, vol. 40, no. 1, pp. 110, 2007. [35] s. sosa-estani, e. cura, e. velazquez, c. yampotis, e. l. segura, etiolog treatment young women infect trypanosoma cruzi, prevent congenit transmission, journal brazilian societi tropic medicine, vol. 42, no. 5, pp. 484487, 2009. [36] d. l. fabbro, e. danesi, v. olivera et al., trypanocid treat- ment ofwomen infect trypanosoma cruzi effect prevent congenit chagas, plo neglect tropic diseases, vol. 8, no. 11, p. e3312, 2014. [37] a. soriano-arandes, l. basile, h. ouaarab et al., control congenit paediatr chaga diseas commun health approach activ surveil promot paediatr awareness, bmc public health, vol. 14, no. 1, 2014. [38] a. requena-mendez, s. bussion, e. aldasoro et al., cost- effect chaga diseas screen latin american migrant primari health-car centr europe: markov model analysis,thelancetglobalhealth, vol. 5, no. 4, pp. e439 e447, 2017. hindawi www.hindawi.com volum 2018 mathemat journal hindawi www.hindawi.com volum 2018 mathemat problem engin appli mathemat journal hindawi www.hindawi.com volum 2018 probabl statist hindawi www.hindawi.com volum 2018 journal hindawi www.hindawi.com volum 2018 mathemat physic advanc complex analysi journal hindawi www.hindawi.com volum 2018 optim journal hindawi www.hindawi.com volum 2018 hindawi www.hindawi.com volum 2018 engin mathemat intern journal hindawi www.hindawi.com volum 2018 oper research advanc journal hindawi www.hindawi.com volum 2018 function space abstract appli analysi hindawi www.hindawi.com volum 2018 intern journal mathemat mathemat scienc hindawi www.hindawi.com volum 2018 hindawi publish corpor volum 2013 hindawi www.hindawi.com scientif world journal volum 2018 hindawi www.hindawi.com volum 2018volum 2018 numer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysisnumer analysi advanc inadv discret dynam natur societi hindawi www.hindawi.com volum 2018 hindawi www.hindawi.com dierenti equat intern journal volum 2018 hindawi www.hindawi.com volum 2018 decis scienc advanc hindawi www.hindawi.com volum 2018 analysi intern journal hindawi www.hindawi.com volum 2018 stochast analysi intern journal submit manuscript www.hindawi.com